---
title: "杭州民生健康药业股份有限公司 (301507.SZ)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/301507.SZ.md"
symbol: "301507.SZ"
name: "杭州民生健康药业股份有限公司"
industry: "个人护理产品"
---

# 杭州民生健康药业股份有限公司 (301507.SZ)

| Item | Detail |
|------|--------|
| Industry | 个人护理产品 |
| Location | 沪深市场 |
| Website | [www.hzmsjk.com](https://www.hzmsjk.com) |

## Company Profile

公司围绕新产品、新项目、新业务、新模式的四新战略，对整体业务、品牌做了新的布局和规划，公司全面进军大健康行业，积极拓展在大健康领域的影响力和竞争力，在品牌同质化浪潮中乘风破局，强势出圈。在推动公司业务发展的同时，更致力于为实现 “健康中国” 的战略目标贡献力量，不负 “提供优质产品，成就他人健康” 的企业使命。公司专注于大健康领域，是集非处方药、保健食品、功能性食品研发、生产、销售于一体的高新技术企业。公司的主要产品为维生素与矿物质补充剂系列产品。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-22T04:30:09.000Z

**Overall: B (0.31)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 11 / 27 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.85% |  |
| Net Profit YoY | 33.21% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 3.41 |  |
| Dividend Ratio | 0.64% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5.53B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 744.11M |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.64% | B |
| Profit Margin | 16.14% | A |
| Gross Margin | 46.90% | B |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.85% | B |
| Net Profit YoY | 33.21% | B |
| Total Assets YoY | 18.72% | A |
| Net Assets YoY | 13.23% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 619.67% | C |
| OCF YoY | 20.85% | B |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.40 | C |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 14.92% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 杭州民生健康药业股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.64%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "16.14%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "46.90%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.85%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "33.21%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "18.72%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "13.23%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "619.67%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "20.85%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.40",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "14.92%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 珀莱雅 (SH.603605) | A | C | A | B | C | B |
| 02 | 飞科电器 (SH.603868) | B | D | A | A | C | B |
| 03 | 丸美生物 (SH.603983) | B | B | B | B | B | B |
| 04 | 天新药业 (SH.603235) | B | B | C | A | C | B |
| 05 | 润本股份 (SH.603193) | A | B | B | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 46.03 | 14/28 | 53.71 | 50.74 | 47.22 |
| PB | 3.41 | 16/28 | 3.45 | 3.24 | 3.09 |
| PS (TTM) | 7.43 | 26/28 | 7.83 | 7.45 | 7.07 |
| Dividend Yield | 0.64% | 15/28 | 0.74% | 0.69% | 0.64% |

## References

- [Company Overview](https://longbridge.com/en/quote/301507.SZ/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/301507.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/301507.SZ/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.